Enlivex Therapeutics Ltd. buy melinda
Start price
25.10.17
/
50%
€21.20
Target price
20.12.17
€22.40
Performance (%)
6.79%
End price
20.12.17
€22.64
Summary
This prediction ended on 20.12.17 with a price of €22.64. With a performance of 6.79%, the BUY prediction by melinda for Enlivex Therapeutics Ltd. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | -20.792% | -20.792% | -32.203% | -79.767% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by melinda for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
Stopped prediction by melinda for Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€19.12
25.10.17
25.10.17
€20.20
20.12.17
20.12.17
6.79%
20.12.17
20.12.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€14.65
26.09.17
26.09.17
€18.04
28.09.17
28.09.17
13.71%
28.09.17
28.09.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€16.24
26.09.17
26.09.17
€20.00
28.09.17
28.09.17
13.71%
28.09.17
28.09.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€47.63
27.01.17
27.01.17
€72.16
27.07.17
27.07.17
-53.77%
27.07.17
27.07.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€185.81
14.10.15
14.10.15
€234.52
14.04.16
14.04.16
-54.95%
14.04.16
14.04.16